StockNews.com lowered shares of Ferroglobe (NASDAQ:GSM – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday.
Ferroglobe Stock Performance
Shares of NASDAQ:GSM opened at $5.52 on Tuesday. The firm has a market capitalization of $1.03 billion, a PE ratio of 16.24 and a beta of 1.87. Ferroglobe has a 12 month low of $4.26 and a 12 month high of $6.78. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.74 and a quick ratio of 1.02. The business has a 50-day moving average of $5.57 and a two-hundred day moving average of $5.41.
Ferroglobe Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, June 27th. Shareholders of record on Monday, June 17th were given a dividend of $0.013 per share. The ex-dividend date of this dividend was Monday, June 17th. This represents a $0.05 dividend on an annualized basis and a yield of 0.94%. Ferroglobe’s dividend payout ratio (DPR) is 14.71%.
Institutional Trading of Ferroglobe
Ferroglobe Company Profile
Ferroglobe PLC operates in the silicon and specialty metals industry in the United States, Europe, and internationally. It provides silicone chemicals that are used in a range of applications, including personal care items, construction-related products, health care products, and electronics, as well as silicon metal for primary and secondary aluminum producers; silicomanganese, which is used as deoxidizing agent in the steel manufacturing process; and ferromanganese that is used as a deoxidizing, desulphurizing, and degassing agent in the removal of nitrogen and other harmful elements from steel.
Further Reading
- Five stocks we like better than Ferroglobe
- How to Calculate Stock Profit
- RXO Shares Surge Following New Acquisition Deal
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Ferroglobe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ferroglobe and related companies with MarketBeat.com's FREE daily email newsletter.